Drug Prescribing Pattern in Dermatophytosis at the Medical Outpatient Clinic of a Tertiary Healthcare in Karnataka, India

Aim of this study is to ascertain the drug prescribing pattern of the patients with Tinea infections attending a tertiary care teaching centre. This retrospective study conducted at a tertiary care teaching hospital in the Dakshina Kannada district, Karnataka for a period of one year. 158 prescriptions were audited to find generic/ brand names of drugs, number of drugs, dosage, forms, frequency, and duration of treatment. The age and sex distributions of patients and disease distribution were also studied. 72 (45.57%) patients were males and 86 (54.43%) were females. Terbinafine, Ketoconazole, Sertaconazole were prescribed as topical monotherapy .Clobetasone butyrate, Sertaconazole and Miconazole were prescribed as topical polytherapy. Terbinafine, Fluconazole and anti histaminics were prescribed as systemic monotherapy and polytherapy. Statistical analysis revealed p-value was > 0.05. Prescription patterns were in consensus with the general guidelines

PDF

___

1. Hanumanthappa H, Sarojini K, Shilpashree P, Muddapur SB. Clinicomycological study of 150 cases of dermatophytosis in a tertiary care hospital in South India. Indian J Dermatol. 2012;57(4):322-3.

2. Bennet JE. Antifungal agents. In: Bruton LL, Chabner BA, Knollmann BJ, eds, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12th edition. New York: Mc-Graw-Hill. 2011;1512.

3. James WD, Berger TG ,Elston DM, eds, Andrew’s Diseases of the Skin: Clincal Dermatology, 11th , edition. Philadelphia: Saunder Elsevier, 2011;288-96.

4. Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149(3):341-9.

5. Delrosso JO, Kircik LH. Optimising topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol. 2013:12(1):165-71.

6. Choudhary S, Bisati S, Singh A, Koley S. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. Indian J Dermatol. 2013;58(6):457- 60.

7. Thakur SJ, Mehta DS, Shah HA, Dave JN, Mundhava SG. A comparative randomosed open level study to evaluate efficacy, safety and cost–effectivenees between topical 2% Sertaconazole and topical 1% Butenafine in Tinea infection of skin. Indian J Dermatol. 2013:58(6):451-6.

8. Jerajani H, Janaki C, Kumar S, Phiske M. Comparative assessment of efficacy and safety of sertaconazole (2%) cream versus terbinafine (1%) cream versus luliconazole (1%) cream in patients of dermatophytosis: a pilot study. Indian J Dermatol. 2013;58(1):34-8.

9. Choudhary SV, Aghi T, Bisati S. Trebinafine hydrochloride 1% cream vs Erboconazloe nitrate 1% cream in localized tinea corporis and tinea cruris. Indian Dermatol Online J. 2014;5(2):128-31.

10. Shivmurthy RPM, Reddy SGH, Kallappa R, Smasekhar SA, Patil D, Patil UN. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study. J Clin Diagn Res. 2014;8(9);HC09- 12.

11. van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2014 Oct 7. [Epub ahead of print]

12. Havlickova B, Friedrich M. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses. 2008;51 Suppl 4:16-26.

13. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. www.update.com/ contents/dermatophyte-tinea-infections access date 07.09.2013

14. Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014;89(2):259-64.